4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Purity

Incazelo emfushane:

4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride

I-CAS: 106261-49-8

Ukubukeka: Impushana Emhlophe Ukuya Kucishe Emhlophe kuya kuCrystal

Ubumsulwa: ≥98.0% (HPLC)

I-Imatinib Mesylate ephakathi (CAS: 220127-57-1) ekwelapheni i-Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali 4--[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
Omqondofana I-Imatinib Mesylate Intermediate
Inombolo ye-CAS 106261-49-8
Inombolo yeCAT I-RF-PI229
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C13H20Cl2N2O2
Isisindo samangqamuzana 307.22
I-Melting Point 305.0~307.0℃
Ukuncibilika Incibilika Emanzini
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe Kuya Kucishe Emhlophe kuya kuCrystal
Ukuhlanzeka / Indlela Yokuhlaziya ≥98.0% (HPLC)
Ukulahlekelwa Ekumisweni ≤0.50%
Izinsalela ekushiseni ≤0.50%
Ukungcola Okuphelele ≤2.0%
Ukungcola Okukodwa Okukhulu ≤1.0%
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Pharmaceutical Intermediate ye-Imatinib Mesylate (CAS: 220127-57-1)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomnikezeli we-4--[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) enekhwalithi ephezulu.Itiyindawo ephakathi ngokuvamile ekuhlanganisweni kwe-Imatinib Mesylate (CAS: 220127-57-1).I-Imatinib Mesylate iyi-tyrosine kinase inhibitor, ecaciselwe kakhulu i-BCR-ABL, isidakamizwa somlomo sokwelashwa kweziguli ezikhulile ezine-Philadelphia chromosome positive chronic myeloid leukemia (CML) esigabeni esibucayi kanye nezinhlobo ezithile ze-acute lymphoblastic leukemia (ALL), isheshisiwe. isigaba kanye nesigaba esingapheli ngemva kokuhluleka kokwelashwa kwe-interferon.

Bhala umyalezo wakho lapha futhi usithumelele wona